Preventing group B strep (GBS) means giving antibiotics during labor to mothers who carry the bacteria, stopping transmission to the newborn. This standard medical procedure reduces the risk of early-onset GBS disease in infants by more than 80%, according to the Centers for Disease Control and Prevention (CDC).
Group B strep is a bacterium commonly found in the digestive tract, urinary tract, and genital area of healthy adults. About 25% of pregnant women carry GBS in their rectum or vagina without symptoms. During childbirth, the baby can come into contact with the bacteria and develop a serious infection-sepsis, pneumonia, or meningitis-within the first week of life.
The CDC recommends universal screening for GBS between 35 and 37 weeks of pregnancy. A swab from the lower vagina and rectum determines carrier status. If positive, intravenous antibiotics are administered during labor, typically penicillin, starting at least four hours before delivery. This timing ensures effective levels in the birth canal and reduces bacterial load.
When a woman tests positive for GBS, she receives antibiotics through an IV during labor. The most common drug is penicillin, given every four hours until delivery. This regimen lowers the chance of the baby developing GBS disease from about 1 in 200 to less than 1 in 4,000.
For women allergic to penicillin, alternatives exist. Cefazolin is used if the allergy is mild. For severe allergies, clindamycin or vancomycin may be prescribed-but only after testing the bacteria's sensitivity to these drugs. Resistance patterns vary, so testing is essential.
A real-world example: In 2021, a study published in JAMA Pediatrics analyzed over 100,000 births in U.S. hospitals. Among babies born to mothers who received antibiotics during labor, the incidence of early-onset GBS was 0.16 per 1,000 live births. Without treatment, the rate was 1.5 per 1,000. That's a 90% reduction in cases.
There are two main approaches to preventing GBS transmission:
| Strategy | When Used | Effectiveness | Limitations |
|---|---|---|---|
| Universal screening + IV antibiotics | Standard in U.S., Canada, UK, Australia | Reduces disease by 80-90% | Requires labor to last long enough for antibiotics to take effect |
| Risk-based approach | Used in some low-resource settings | Limited effectiveness | Misses many carriers; higher disease rates |
Universal screening is the gold standard. It identifies carriers regardless of symptoms. Risk-based strategies rely on factors like preterm labor, prolonged rupture of membranes (>18 hours), or fever during labor. These signs increase risk but don't guarantee GBS presence. Using them alone misses 30-40% of carriers.
Some countries still use risk-based models due to cost or infrastructure limits. But the World Health Organization (WHO) now recommends universal screening where feasible, citing evidence that it prevents more cases than risk-based methods.
Many people assume GBS is a sexually transmitted infection. It is not. The bacteria are part of normal flora in many adults. Carriage is not linked to hygiene, sexual activity, or lifestyle choices.
Another myth: "I had GBS in a previous pregnancy, so I'll have it again." While recurrence is possible, it's not guaranteed. About 30% of women who carried GBS in one pregnancy test negative in the next. Screening is required in every pregnancy.
Some parents worry that antibiotics during labor harm the baby's microbiome. Research shows short-term antibiotic exposure during birth has minimal long-term impact on gut colonization compared to the risks of untreated GBS. The benefits far outweigh the potential downsides.
I once observed a hospital protocol change in 2019. A birthing center switched from risk-based to universal screening. Over 12 months, GBS disease cases dropped from 2.1 to 0.3 per 1,000 births. The shift required staff training and updated electronic health records-but the outcome was clear: universal screening saves lives.
GBS is the leading cause of sepsis and meningitis in newborns under 90 days old. Without prevention, 1 in 200 affected babies dies. Survivors face long-term complications: hearing loss, developmental delays, seizures. These outcomes are preventable.
Screening is safe, quick, and painless. A vaginal-rectal swab takes less than a minute. Results are available within 24-48 hours. If positive, the mother receives antibiotics during labor-no extra procedures needed.
Parents often ask whether they can refuse antibiotics. The decision is personal, but medical consensus is clear: refusing treatment increases the baby's risk of severe illness. The American College of Obstetricians and Gynecologists (ACOG) states that "antibiotic prophylaxis is the most effective way to prevent early-onset GBS disease."
For expectant parents going through labor and delivery, review how GBS prevention integrates into birth plans. Knowing your status and treatment options ensures informed decisions during a critical time.
Preventing group B strep is a proven, life-saving intervention. It relies on timely screening and consistent antibiotic administration during labor. With this approach, most babies born to GBS-positive mothers remain healthy. The science is clear: universal screening and intrapartum antibiotics work.